MarketCap
Facebook
X
TelegramAnnual report 2025
added 04-04-2026
InMode Ltd. Total Non Current Liabilities 2011-2026 | INMD
Annual Total Non Current Liabilities InMode Ltd.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12.5 M | 12 M | 11.8 M | 7.77 M | 10.9 M | 5.26 M | 6.09 M | 4.76 M | 6.53 M | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 12.5 M | 4.76 M | 8.62 M |
Quarterly Total Non Current Liabilities InMode Ltd.
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 10.9 M | - | - | - | 5.26 M | - | - | - | 6.09 M | - | - | - | 4.76 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 10.9 M | 4.76 M | 6.75 M |
Total Non Current Liabilities of other stocks in the Medical devices industry
| Issuer | Total Non Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AxoGen
AXGN
|
1.61 M | $ 32.81 | 5.87 % | $ 1.51 B |  USA |
 |
Conformis
CFMS
|
29.2 M | - | - | $ 16.4 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
85.2 M | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
44 M | - | -26.83 % | $ 2.62 M | USA |
 |
AdaptHealth Corp.
AHCO
|
424 M | $ 12.36 | 3.48 % | $ 1.67 B | USA |
 |
Cardiovascular Systems
CSII
|
28.3 M | - | 0.15 % | $ 844 M | USA |
 |
Allied Healthcare Products
AHPI
|
115 K | - | 3.58 % | $ 2.21 M | USA |
 |
ClearPoint Neuro
CLPT
|
23.9 M | $ 9.39 | 3.53 % | $ 266 M | USA |
 |
Dynatronics Corporation
DYNT
|
10 M | - | 14.99 % | $ 929 K | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
906 K | - | -5.86 % | $ 30.6 M | USA |
 |
Bruker Corporation
BRKR
|
1.28 B | $ 38.22 | 4.23 % | $ 5.7 K | USA |
 |
Second Sight Medical Products
EYES
|
2.36 M | - | -0.97 % | $ 54.4 M | USA |
 |
Apollo Endosurgery
APEN
|
59 M | - | - | $ 475 M | USA |
 |
Electromed
ELMD
|
8.87 K | $ 24.45 | 2.8 % | $ 207 M | USA |
 |
FONAR Corporation
FONR
|
36.4 M | $ 18.61 | 0.13 % | $ 122 M | USA |
 |
EDAP TMS S.A.
EDAP
|
7.44 M | $ 3.38 | -0.59 % | $ 127 M |  France |
 |
CryoLife, Inc.
CRY
|
400 M | - | -4.14 % | $ 702 M | USA |
 |
Avinger
AVGR
|
12.7 M | - | -20.74 % | $ 369 K | USA |
 |
Align Technology
ALGN
|
184 M | $ 178.65 | 7.06 % | $ 13.4 B | USA |
 |
Globus Medical
GMED
|
18.2 M | $ 91.76 | 1.91 % | $ 12.4 B | USA |
 |
Invacare Corporation
IVC
|
325 M | - | - | $ 24.7 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
24.8 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
35.2 M | - | 1.37 % | $ 20.5 M | USA |
 |
Soliton, Inc.
SOLY
|
4.28 K | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
568 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
3.08 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
39.9 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
8.24 M | - | - | $ 111 M |  Canada |
 |
Intersect ENT, Inc.
XENT
|
116 M | - | - | $ 955 M | USA |
 |
Helius Medical Technologies
HSDT
|
252 K | $ 1.91 | 4.37 % | $ 1.16 M | USA |
 |
Nevro Corp.
NVRO
|
183 M | - | - | $ 217 M | USA |
 |
Cytosorbents Corporation
CTSO
|
14 M | $ 0.64 | 4.94 % | $ 39.8 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
1.56 B | $ 9.69 | 3.86 % | $ 746 M | USA |
 |
BIOLASE
BIOL
|
5.69 M | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
2.52 M | $ 9.87 | 2.02 % | $ 354 M | USA |
 |
BioSig Technologies
BSGM
|
103 K | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
11.8 B | $ 62.67 | 1.33 % | $ 92.8 B | USA |
 |
Alphatec Holdings
ATEC
|
89.9 M | $ 11.53 | 4.49 % | $ 1.73 B | USA |
 |
IRIDEX Corporation
IRIX
|
2.33 M | $ 1.14 | 10.19 % | $ 19.3 M | USA |
 |
CONMED Corporation
CNMD
|
877 M | $ 36.63 | 5.96 % | $ 1.14 B | USA |
 |
Integer Holdings Corporation
ITGR
|
1.02 B | $ 87.27 | 2.49 % | $ 3.03 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
116 M | $ 16.33 | 3.62 % | $ 383 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
1.44 B | $ 82.18 | 1.68 % | $ 48.1 B | USA |
 |
Inspire Medical Systems
INSP
|
24.6 M | $ 53.86 | -1.01 % | $ 1.58 B | USA |
 |
LivaNova PLC
LIVN
|
516 M | $ 64.88 | 2.11 % | $ 3.54 B |  Britain |
 |
LENSAR
LNSR
|
3.44 M | $ 5.7 | 1.24 % | $ 68.2 M | USA |